Evestra Snags DoD Grant For Experimental Breast Cancer Drug Research

By David Holley, Xconomy San Antonio—A small Texas biotech that develops women’s health ...

Promising Treatment for Ebola Virus to be Tested at Texas Biomed

Ricardo Carrion, Jr., Ph.D. During the West African Ebola outbreak that began in 2013, an experimental ...

San Antonio biotech to get city money to augment its war on cancer
March 9, 2017

BioAffinity Technologies President and CEO Maria Zannes says an investment from the city of San Antonio is a critical endorsement. CARLOS JAVIER SANCHEZ | SABJ

By W. Scott Bailey, San Antonio Business Journal

City Council authorized the San Antonio Economic Development Corporation on Thursday to directly invest in bioAffinity Technologies. It's another indication that City Hall is looking to strengthened its commitment to the community's bioscience industry.

The SAEDC has been given the green light to invest $150,000 in bioAffinity, a San Antonio-based biotech company focused on what its leadership contends is an unmet need for non-invasive, early-stage cancer diagnostics and improved cancer treatments. As part of its agreement with bioAffinity, the company will be required to accelerate job creation and keep its headquarters in San Antonio.

"This investment is important on multiple levels," bioAffinity President and CEO Maria Zannes told me. "Certainly, it establishes us as a San Antonio biotech company. It's also important because it shows the city has recognized our advancement."

The San Antonio Development Corporation is a nonprofit organization established by City Council in 2010 to help facilitate economic development projects and to create new avenues for the city to secure equity in select companies.

City Manager Sheryl Sculley said the decision to invest in bioAffinity will create another opportunity for local leaders to help bring more high-wage jobs to San Antonio.

Meanwhile, Ed Davis, executive director of SAEDC, said local leaders have chosen to put their support behind a company that has an opportunity to become a global player in the war on cancer.


Stay informed. Subscribe to BioMed SA news alerts.